These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 33931005)
21. Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system. Pamreddy A; Baijnath S; Naicker T; Ntshangase S; Mdanda S; Lubanyana H; Kruger HG; Govender T RSC Adv; 2018 Mar; 8(22):11902-11907. PubMed ID: 35539382 [TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics of bedaquiline in patients with drug-resistant TB. Zhu H; Xie L; Liu ZQ; Wang B; Gao MQ; Lu Y Int J Tuberc Lung Dis; 2021 Dec; 25(12):1006-1012. PubMed ID: 34886931 [No Abstract] [Full Text] [Related]
23. A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments. Byun JY; Kim HL; Lee EK; Kwon SH Front Pharmacol; 2021; 12():736986. PubMed ID: 34966276 [No Abstract] [Full Text] [Related]
24. Starting an All-Oral Longer Regimen in a Primary Multidrug-Resistant Pulmonary Tuberculosis Patient at a District Tuberculosis Center for the First Time: A Rare Case. Yadav S Cureus; 2022 Jul; 14(7):e27146. PubMed ID: 36004032 [TBL] [Abstract][Full Text] [Related]
25. A pharmacoeconomic evaluation of the pharmacotherapeutic options for painful diabetic neuropathy. Zhu J; Li W; Shi C; Li Q Expert Opin Pharmacother; 2022 Apr; 23(5):551-559. PubMed ID: 35084270 [TBL] [Abstract][Full Text] [Related]
26. Application of Chiral Transfer Reagents to Improve Stereoselectivity and Yields in the Synthesis of the Antituberculosis Drug Bedaquiline. Robey JMS; Maity S; Aleshire SL; Ghosh A; Yadaw AK; Roy S; Mear SJ; Jamison TF; Sirasani G; Senanayake CH; Stringham RW; Gupton BF; Donsbach KO; Nelson RC; Shanahan CS Org Process Res Dev; 2023 Nov; 27(11):2146-2159. PubMed ID: 38025988 [TBL] [Abstract][Full Text] [Related]
27. Improved Synthesis and Isolation of Bedaquiline. Lubanyana H; Arvidsson PI; Govender T; Kruger HG; Naicker T ACS Omega; 2020 Feb; 5(7):3607-3611. PubMed ID: 32118176 [TBL] [Abstract][Full Text] [Related]
28. Synergistic Li/Li Bimetallic System for the Asymmetric Synthesis of Antituberculosis Drug TBAJ-587. Ahmad T; Gao F; Li J; Zhang Z; Song T; Yuan Q; Zhang W J Org Chem; 2023 Jun; 88(11):7601-7606. PubMed ID: 37125776 [TBL] [Abstract][Full Text] [Related]
29. Pharmacoeconomic Trends, Applications, and Potential Developments. Rocha-Gonçalves FN Glob J Qual Saf Healthc; 2020 May; 3(2):36-37. PubMed ID: 37334152 [No Abstract] [Full Text] [Related]
30. Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014-2018. Bahizi G; Majwala RK; Kisaka S; Nyombi A; Musisi K; Kwesiga B; Bulage L; Ario AR; Turyahabwe S Antimicrob Resist Infect Control; 2021 May; 10(1):76. PubMed ID: 33964986 [TBL] [Abstract][Full Text] [Related]
31. Genomic epidemiology of tuberculosis in eastern Malaysia: insights for strengthening public health responses. Bainomugisa A; Meumann EM; Rajahram GS; Ong RT; Coin L; Paul DC; William T; Coulter C; Ralph AP Microb Genom; 2021 May; 7(5):. PubMed ID: 33945455 [TBL] [Abstract][Full Text] [Related]
34. Comparative Utility of Genetic Determinants of Drug Resistance and Phenotypic Drug Susceptibility Profiling in Predicting Clinical Outcomes in Patients With Multidrug-Resistant Che Y; Yang T; Lin L; Xiao Y; Jiang F; Chen Y; Chen T; Zhou J Front Public Health; 2021; 9():663974. PubMed ID: 33968888 [No Abstract] [Full Text] [Related]
35. Comparison of toxin-antitoxin expression among drug-susceptible and drug-resistant clinical isolates of Mycobacterium tuberculosis. Kazemian H; Heidari H; Kardan-Yamchi J; Ghafourian S; Pakzad I; Kouhsari E; Valadbeigi H; Sadeghifard N Adv Respir Med; 2021; 89(2):110-114. PubMed ID: 33966258 [TBL] [Abstract][Full Text] [Related]
36. Treatment and outcomes of multidrug-resistant tuberculosis in Auckland, 1995-2018. Cutfield T; Mowlem L; Paynter J; Christmas T; Harrison A; Lewis C; Newton S; Nisbet M Intern Med J; 2022 Aug; 52(8):1381-1386. PubMed ID: 33961727 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review. Bigio J; Kohli M; Klinton JS; MacLean E; Gore G; Small PM; Ruhwald M; Weber SF; Jha S; Pai M PLoS One; 2021; 16(5):e0251236. PubMed ID: 33961639 [TBL] [Abstract][Full Text] [Related]
38. Recent Insights into the Structure and Function of Mycobacterial Membrane Proteins Facilitated by Cryo-EM. Bendre AD; Peters PJ; Kumar J J Membr Biol; 2021 Jun; 254(3):321-341. PubMed ID: 33954837 [TBL] [Abstract][Full Text] [Related]
39. Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial. Griesel R; Hill A; Meintjes G; Maartens G Wellcome Open Res; 2021; 6():1. PubMed ID: 33954265 [TBL] [Abstract][Full Text] [Related]